Related by context. Frequent words. (Click for all words.) 68 ADAS cog 66 Alzheimer Disease Assessment 65 PANSS 64 Main Outcome Measures 64 Solid Tumors 64 creatinine clearance 63 Negative Syndrome 63 Secondary endpoints include 63 Expanded Disability Status 62 Prognostic 62 Response Evaluation Criteria 62 J Am Coll 62 Disease Activity 62 Secondary endpoints included 62 Thrombolysis 62 achieved statistical significance 61 Ischemic 61 TAXUS p value 61 DAS# [002] 61 glomerular filtration rate 61 carotid intima media 60 Study Demonstrates 60 Taxus Stent 60 annualized relapse 60 fraction LVEF 60 Meta Analysis 60 estimated glomerular filtration 60 Benign Prostatic Hyperplasia 59 Unified Parkinson Disease 59 Overactive Bladder 59 Chronic Heart Failure 59 Secondary endpoints 59 Heart Failure Patients 59 Clinical Trial Results 59 tirofiban 59 ACR# response 59 left ventricular systolic 59 symptom severity 59 QTc 59 sensitivity specificity 58 placebo p = 58 plus prednisone 58 CYP#C# [002] 58 serum phosphorus 58 Acute Myocardial Infarction 58 MADRS 58 univariate 58 Adalimumab 58 statistically significant p = 58 Significantly Reduces 58 plus methotrexate 58 C Reactive Protein 58 #mg/day [001] 58 Arch Intern Med 58 severe renal impairment 57 hypomagnesemia 57 Pegasys ® 57 fasting insulin 57 Cardiovascular Events 57 Pivotal Phase III 57 Natalizumab 57 Nephrol 57 Postmenopausal Women 57 plus dexamethasone 57 PsA 57 platelet reactivity 57 Elderly Patients 57 T2DM 57 QTc interval 57 tolvaptan 57 Pioglitazone 57 thromboembolic 57 XIENCE V vs. 57 Ann Intern Med 57 apolipoprotein B 56 N Engl J 56 Atopic Dermatitis 56 RECIST criteria 56 CI -#.# 56 erythrocyte sedimentation rate 56 Lantus ® 56 POAG 56 irbesartan 56 RECIST 56 mucosal healing 56 Thrombocytopenia 56 confidence interval #.#-#.# 56 % CI #.#-#.# [003] 56 juvenile idiopathic arthritis 56 Postoperative 56 pharmacodynamic effects 56 Patients Treated 56 Am J Cardiol 56 Drug Candidate 56 Hepatic 56 Cardiol 56 Blood Glucose 56 Natural Catastrophe Stress 56 peripheral blood mononuclear 56 Monotherapy 56 hsCRP